April 29, 2015
Actos® is a medication used to treat diabetes in thousands of Americans over the past decade. But the Actos drug injury lawyers at Stewart & Stewart Attorneys explain the drug was linked to an increased risk of some patients developing bladder cancer. Now, those victims may be one step closer to getting the compensation they deserve.
The company that manufactures Actos, Takeda Pharmaceutical, has offered to settle the majority of the approximately 9,000 outstanding Actos drug injury lawsuits for an estimated $2.4 billion. Bloomberg Business reports that if 95 percent of the plaintiffs agree to the terms of the settlement, each of the victims would receive around $296,000 in compensation.
The announcement comes in the wake of last year’s decision by a federal grand jury finding Takeda and its partner, Eli Lilly & Co., responsible for paying $9 billion in damages to a man who claimed Actos caused him to develop bladder cancer. The award was later reduced to $36.8 million.
As part of the settlement, Takeda will not accept liability for the harm patients suffered.
At Stewart & Stewart Attorneys, we understand the hardships the victims have faced in their journey to receive the compensation they deserve. That’s why our Indianapolis personal injury lawyers are hopeful the settlement will help bring closure to those adversely affected by the drug.